FDA Clears Magstim Transcranial Magnetic Stimulation System for U.S. Adolescent Patient Treatment
MINNEAPOLIS, March 19, 2025 (GLOBE NEWSWIRE) -- Major depression impacts more than 5 million U.S. adolescents every year, and NIH data shows that 20% of those aged 12 to 16 have had at least one major depressive episode*. The FDA has now cleared the …